News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
McWherter Charles
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 21,746 shares
@ $11.4669, valued at
$249.4k
Exercised 10,404 options to buy
@ $5, valued at
$52k
Exercised 708 options to buy
@ $5, valued at
$3.5k
Exercised 236 options to buy
@ $5, valued at
$1.2k
Exercised 3,892 options to buy
@ $5, valued at
$19.5k
Exercised 6,506 options to buy
@ $5, valued at
$32.5k
|
|
07/19/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 21,749 shares
@ $11.4267, valued at
$248.5k
Exercised 10,407 options to buy
@ $5, valued at
$52k
Exercised 708 options to buy
@ $5, valued at
$3.5k
Exercised 236 options to buy
@ $5, valued at
$1.2k
Exercised 3,892 options to buy
@ $5, valued at
$19.5k
Exercised 6,506 options to buy
@ $5, valued at
$32.5k
|
|
05/19/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Sold 21,749 shares
@ $9.0757, valued at
$197.4k
Exercised 10,407 options to buy
@ $5, valued at
$52k
Exercised 708 options to buy
@ $5, valued at
$3.5k
Exercised 236 options to buy
@ $5, valued at
$1.2k
Exercised 3,892 options to buy
@ $5, valued at
$19.5k
Exercised 6,506 options to buy
@ $5, valued at
$32.5k
|
|
01/27/2023 |
4
| McWherter Charles (President of R&D) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 300,000 options to buy
@ $7.8, valued at
$2.3M
|
|
01/27/2022 |
4
| McWherter Charles (Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 225,000 options to buy
@ $2.94, valued at
$661.5k
|
|
01/28/2021 |
4
| McWherter Charles (Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 112,000 options to buy
@ $5.78, valued at
$647.4k
|
|
05/19/2020 |
4
| McWherter Charles (SVP & Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 328,299 options to buy
@ $4.05, valued at
$1.3M
|
|
01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2018 |
4
| McWherter Charles (Chief Science Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 150,000 options to buy
@ $11.69, valued at
$1.8M
|
|
11/06/2017 |
4
| McWherter Charles (SVP & Chief Scientific Officer) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Bought 300 shares
@ $8.67, valued at
$2.6k
Bought 4,700 shares
@ $8.668, valued at
$40.7k
|
|
07/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/19/2016 |
4
| McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Bought 3,000 shares
@ $1.68, valued at
$5k
|
|
01/28/2016 |
4
| McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 54,000 options to buy
@ $1.06, valued at
$57.2k
|
|
05/19/2015 |
4
| McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Bought 400 shares
@ $3.14, valued at
$1.3k
Bought 600 shares
@ $3.169, valued at
$1.9k
Bought 1,000 shares
@ $3.161, valued at
$3.2k
|
|
01/08/2015 |
4
| McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Granted 100,000 options to buy
@ $10, valued at
$1M
|
|
01/08/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/27/2013 |
4
| McWherter Charles (Sr. Vice President) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns:
| Disposed/sold 5,660 options to buy
@ $39.75, valued at
$225k
Granted 5,660 options to buy
@ $5, valued at
$28.3k
Disposed/sold 1,886 options to buy
@ $15.9, valued at
$30k
Granted 1,886 options to buy
@ $5, valued at
$9.4k
Granted 31,134 options to buy
@ $5, valued at
$155.7k
|
|
11/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|